Search by Drug Name or NDC
NDC 42515-0003-01 IXCHIQ 3 [TCID_50]/.5mL Details
IXCHIQ 3 [TCID_50]/.5mL
IXCHIQ is a INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the VACCINE category. It is labeled and distributed by Valneva Scotland Ltd.. The primary component is CHIKUNGUNYA VIRUS LR2006 OPY1 (ATTENUATED STRAIN) ANTIGEN.
Product Information
| NDC | 42515-0003 |
|---|---|
| Product ID | 42515-003_b4290037-5386-49ef-b886-642b95e8d4cf |
| Associated GPIs | |
| GCN Sequence Number | 085497 |
| GCN Sequence Number Description | chikungunya vaccine, live/PF VIAL 1000 TCID INTRAMUSC |
| HIC3 | W7B |
| HIC3 Description | VIRAL/TUMORIGENIC VACCINES |
| GCN | 54998 |
| HICL Sequence Number | 049303 |
| HICL Sequence Number Description | CHIKUNGUNYA VACCINE, LIVE/PRESERVATIVE FREE |
| Brand/Generic | Brand |
| Proprietary Name | IXCHIQ |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chikungunya Vaccine, Live-Attenuated |
| Product Type | VACCINE |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | [TCID_50]/.5mL |
| Substance Name | CHIKUNGUNYA VIRUS LR2006 OPY1 (ATTENUATED STRAIN) ANTIGEN |
| Labeler Name | Valneva Scotland Ltd. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125777 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42515-0003-01 (42515000301)
| NDC Package Code | 42515-003-01 |
|---|---|
| Billing NDC | 42515000301 |
| Package | 1 SYRINGE in 1 CARTON (42515-003-01) / .5 mL in 1 SYRINGE (42515-003-00) |
| Marketing Start Date | 2024-01-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |